查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2028468

全球生物分析檢測服務市場：依檢測類型、檢測方式、最終用戶與地區分類－趨勢與預測（至2035年）

Bioanalytical Testing Services Market by Type of Testing, Type of Modality, End-user, and Geographical Regions - Trends and Forecast, Till 2035
出版日期: | 出版商: Roots Analysis | 英文 263 Pages | 商品交期: 最快1-2個工作天內

價格

生物分析檢測服務市場概覽

預計到 2035 年，生物分析測試服務市場將以 7.3% 的複合年成長率成長，從目前的 31.1 億美元成長到 58.8 億美元。

生物分析檢測服務市場－成長與趨勢

生物分析試驗是分析生物檢體以評估候選藥物的安全性、有效性和藥理特性的關鍵過程。透過這些研究獲得的見解使研究人員能夠了解藥物在人體內的作用機制並評估其治療效果。此外，生物分析試驗在支持監管合規和促進產品及時核准也發揮著至關重要的作用。

隨著先進和個人化治療方法的不斷發展，對生物分析檢測解決方案（包括生物標記分析、藥物動力學研究和生物等效性評估）的需求急劇成長。然而，在藥物研發日益複雜的背景下，如何在推動研究計畫的同時保持強大的生物分析能力，是一項挑戰。

此外，建立內部生物分析實驗室需要大量資金投入，而有效率運作則需要高技能人員。為了應對這些挑戰，許多製藥公司擴大將生物分析檢測外包給專業服務供應商。這種方式能夠獲得先進的技術專長，減輕高通量基礎設施相關的經濟負擔，並確保使用先進的分析平台進行準確可靠的樣品評估。

成長要素：市場擴張的策略促進因素

生物分析檢測市場的成長受多種成長要素驅動。質譜、層析法和免疫檢測等分析技術的不斷進步正在顯著改變生物分析檢測的模式。自動化和人工智慧的融合進一步提高了靈敏度、處理能力和數據準確性。

此外，多組體學方法與人工智慧驅動分析的融合正在加速生物標記的發現和檢驗，使生物分析服務成為精準醫療的關鍵驅動力。這些創新不僅提高了分析的可靠性，簡化了方法檢驗流程，還有助於更快、更有效率地發現新藥。

在此背景下，製藥和生物技術公司擴大將生物分析試驗外包給合約研究組織（CRO），以最佳化成本、利用專業知識並應對新藥研發模式日益複雜的挑戰。這種方法還有助於確保符合嚴格的監管要求，從而提高研發的整體效率和競爭力。

市場挑戰：阻礙進展的主要障礙

儘管生物分析檢測市場具有上述優勢，但仍面臨許多挑戰，導致營運摩擦和策略風險。其中一個主要阻礙因素是新型藥物模式（包括生物製藥、細胞和基因療法）日益複雜。這些藥物需要專門的分析技術、先進的儀器和持續的最佳化，導致研發時間和成本的增加。此外，滿足日益嚴格且不斷變化的分析方法驗證、資料完整性和合規性方面的監管要求需要投入大量資源和專業知識，這往往會阻礙研究的進行。

綜合考慮所有這些因素，持續的技術升級、培養熟練的人員以及策略性外包對於確保生物分析測試生態系統內的營運效率和監管合規性至關重要。

生物分析檢測服務市場—關鍵洞察

本報告詳細分析了生物分析檢測服務市場的現狀，並指出了該行業的潛在成長機會。報告的主要發現包括：

  • 目前市場上，全球約有120家供應商聲稱提供生物分析檢測服務。值得注意的是，其中近45%的供應商位於北美。
生物分析檢測服務市場-IMG1
  • 絕大多數服務供應商（90%）提供藥物動力學測試，尤其是這些公司，具備滿足製藥和生技公司需求的所有必要能力。
生物分析檢測服務市場-IMG2
  • 質譜分析等分析技術的進步以及人工智慧的整合，正在推動生物分析測試服務市場的發展，預計到 2035 年，該市場將以 7.3% 的複合年成長率成長。
生物分析檢測服務市場-IMG3
  • 預計今年北美將在整體生物分析檢測服務市場中佔相當大的市場佔有率，但這種趨勢預計不會持續下去。
  • 受眾多具體因素的推動，包括眾多服務供應商的存在以及先進技術的便捷獲取，美國生物分析測試服務市場預計將穩定成長。

生物分析檢測服務市場

市場規模和機會分析是根據以下參數進行細分的：

按測試類型

  • 藥物動力學
  • 動態
  • 生物等效性
  • 其他考試

依模態類型

  • 單株抗體
  • 細胞療法
  • 基因治療
  • 生物相似藥
  • 融合蛋白
  • 傳統的病毒為基礎的治療方法
  • 其他生物製藥
  • 最終用戶

最終用戶

  • 製藥和生物技術公司
  • 受託研究機構/合約開發和製造機構
  • 學術和研究機構
  • 按地區

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 亞太其他地區
  • 中東和北非
  • 沙烏地阿拉伯
  • 埃及
  • 中東和北非其他地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲

生物檢測市場－主要細分市場

藥物動力學是生物分析測試領域的發展驅動力。

根據生物分析檢測服務市場的數據，藥物動力學子領域目前佔45%的市場佔有率，在了解藥物的吸收、分佈、代謝和排泄方面發揮著至關重要的作用。這些因素會影響藥物研發和監管核准過程中的安全性評估、療效評估和劑量最佳化。在預測期內，生物等效性檢測預計將以更高的複合年成長率成長，顯示其具有巨大的成長潛力。這一趨勢的驅動力來自全球各國政府和保險公司為促進生物相似藥和學名藥的應用而採取的舉措，旨在降低藥品成本並改善患者的用藥可及性。

生物技術和製藥公司是該行業的主要驅動力。

根據對生物分析檢測服務市場的預測，受先進分子檢測技術日益普及的推動，製藥和生物技術公司今年預計將佔約50%的市場。這主要歸功於這些公司雄厚的資本投入、卓越的研發能力以及旨在應對日益成長的全球健康負擔的強大前沿生物製藥產品線。在預測期內，合約研究組織 (CRO) 和合約開發與受託製造廠商(CDMO) 的複合年成長率預計將達到8.6%，顯示其具有巨大的成長潛力。

北美市場主導。

預計到2035年，北美將佔生物分析檢測市場最大的佔有率（50%）。這主要是由於製藥和生物技術公司對生物分析檢測服務的巨大需求推動了這一需求。

亞太地區生物分析檢測市場的成長

在預測期內，亞太地區的生物分析檢測服務市場預計將以 8.6% 的複合年成長率成長。這主要歸功於該地區生物技術和製藥行業的研發和臨床試驗活動的快速擴張。

第一次調查總結

本研究的觀點和見解受到了該領域多位相關人員的討論的影響。本市場報告包含與以下相關人員的詳細訪談記錄：

  • 澳洲一家中型公司負責業務拓展的負責人

此外，這份生物分析檢測服務市場報告還包含與以下第三方進行的討論記錄：

  • 美國大型企業的創辦人兼執行長
  • 新加坡小規模機構全球生物分析服務執行副總裁
  • 首席研究員，美國
  • 美國大型企業執行董事
  • 法國某大型機構研發經理
  • 美國某大型企業資深科學家
  • 美國某大型研究機構主任
  • 美國某大型企業生物分析營運主管
  • 法國某大型企業發展主管
  • 加拿大某大型企業董事

生物分析檢測服務市場主要企業範例

  • BioAgilytix
  • Catalent
  • Charles River Laboratories
  • Clean Cells
  • Coriolis Pharma
  • Eurofins
  • Genezen
  • SGS
  • Solvias
  • Texcell
  • Wuxi AppTec

生物分析檢測市場—研究範圍

  • 市場規模和機會分析：本報告對生物分析測試市場進行了詳細分析，重點關注關鍵市場細分，例如 [A] 測試類型、[B] 模式類型、[C] 最終用戶和 [D] 地區。
  • 生物分析檢測市場概覽：除了對醫療設備契約製造市場的整體市場狀況進行詳細評估外，本報告還包括以下幾個相關參數的信息，例如 [A] 成立年份，[B] 公司規模，[C] 總部所在地，[D] 提供的測試類型，[E] 模式類型，[F] 工作流程類型，[G] 技術用戶，以及 [H] 最終用戶。
  • 公司簡介：醫療設備契約製造市場主要企業的詳細簡介，基於[A]成立年份，[B]總部所在地，[C]產品系列，[D]近期發展，以及[E]基於資訊的未來展望。
  • 公司競爭分析：基於[A]公司優勢、[B]服務優勢和[C]最終用戶數量對生物分析測試服務供應商進行競爭分析。
  • 市場影響分析：本報告詳細分析了可能影響生物分析檢測服務市場成長的因素，包括[A]關鍵促進因素、[B]潛在阻礙因素、[C]新興機會和[D]現有挑戰的識別和市場分析。

目錄

第1章 背景

第2章：調查方法

第3章 市場動態

第4章 宏觀經濟指標

第5章摘要整理

第6章：引言

  • 章節概要
  • 生物分析檢測服務概述
  • 生物分析測試類型
  • 生物分析測試的優勢
  • 生物分析測試的挑戰
  • 生物分析測試領域的最新趨勢
  • 未來展覽展望

第7章 市場狀況

  • 生物分析檢測服務供應商：市場概覽

第8章：企業競爭力分析

  • 調查方法和關鍵參數
  • 評分標準
  • Peer Group

第9章 公司簡介：生物分析檢測服務供應商

  • BioAgilytix Labs
  • Catalent
  • Charles River Laboratories
  • Clean Cells
  • Coriolis Pharma
  • Eurofins
  • SGS
  • Solvias
  • Texcells
  • Wuxi Apptech

第10章 市場影響分析

  • 章節概要
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場挑戰

第11章：全球生物分析檢測市場

第12章：生物分析檢測市場（依檢測類型分類）

第13章：生物分析檢測市場（依檢測方式類型分類）

第14章：生物分析檢測市場（依最終用戶分類）

第15章：生物分析檢測市場（按地區分類）

第16章 市場機會分析：北美

第17章 市場機會分析：歐洲

第18章 市場機會分析：亞太地區

第19章 市場機會分析：拉丁美洲

第20章 市場機會分析：中東與北非

第21章：高階主管洞察

第22章附錄1：表格發泡式數據

第23章 附錄2：公司與組織列表

Product Code: RAU1241

Bioanalytical Testing Services Market: Overview

As per Roots Analysis, the bioanalytical testing services market is estimated to grow from USD 3.11 billion in the current year to USD 5.88 billion by 2035, at a CAGR of 7.3% during the forecast period, till 2035.

Bioanalytical Testing Services Market: Growth and Trends

Bioanalytical testing is a critical process involving the analysis of biological samples to evaluate the safety, efficacy, and pharmacological profile of drug candidates. The insights generated through such studies enable researchers to understand drug behavior within the human body and assess therapeutic effectiveness. Additionally, bioanalytical testing plays a vital role in supporting regulatory compliance and facilitating timely product approvals.

With the increasing shift toward advanced and personalized therapeutics, there has been a notable rise in demand for bioanalytical testing solutions, including biomarker analysis, pharmacokinetic studies, and bioequivalence assessments. However, the growing complexity of drug development presents challenges in simultaneously advancing research programs while maintaining robust bioanalytical capabilities.

Moreover, the establishment of in-house bioanalytical laboratories involves significant capital investment and requires highly skilled personnel for efficient operation. In response to these challenges, many pharmaceutical companies are increasingly outsourcing bioanalytical testing to specialized service providers. This approach enables access to advanced technical expertise, reduces the financial burden associated with high-throughput infrastructure, and ensures the use of advanced analytical platforms for precise and reliable sample evaluation.

Growth Drivers: Strategic Enablers of Market Expansion

The growth of bioanalytical testing market is driven by various growth drivers. Ongoing advancements in analytical technologies, including mass spectrometry, chromatography, and immunoassays, are significantly transforming the bioanalytical testing landscape. The integration of automation and artificial intelligence is further enhancing sensitivity, throughput, and data accuracy.

Further, the convergence of multi-omics approaches with AI-driven analytics is accelerating biomarker discovery and validation, positioning bioanalytical services as critical enablers of precision medicine. These innovations not only improve analytical reliability and streamline method validation processes but also support faster and more efficient drug development.

In this context, pharmaceutical and biotechnology companies are increasingly outsourcing bioanalytical testing to contract research organizations (CROs) to optimize costs, access specialized expertise, and address the rising complexity of novel drug modalities. This approach also supports compliance with stringent regulatory requirements, thereby enhancing overall development efficiency and competitive positioning.

Market Challenges: Critical Barriers Impeding Progress

Despite the abovementioned advantages, the bioanalytical testing market faces significant hurdles, that introduce operational friction and strategic risks. A key constraint is the growing complexity of novel drug modalities, including biologics and cell and gene therapies. These require specialized analytical methods, advanced instrumentation, and ongoing optimization, increasing development timelines and costs. In addition, stringent and evolving regulatory requirements for method validation, data integrity, and compliance necessitate significant resource allocation and expertise, often creating bottlenecks in study execution.

Collectively, these factors necessitate continuous technological upgrades, skilled workforce development, and strategic outsourcing to ensure operational efficiency and regulatory compliance within the bioanalytical testing ecosystem.

Bioanalytical Testing Services Market: Key Insights

The report delves into the current state of the bioanalytical testing services market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • The current market landscape features the presence of close to 120 providers that claim to offer bioanalytical testing services across the world; notably, close to 45% of these providers are based in North America.
Bioanalytical Testing Services Market - IMG1
  • Majority (90%) of the service providers offer pharmacokinetics testing; notably, these players possess all the required capabilities required to cater to the demands of pharmaceutical and biotech companies.
Bioanalytical Testing Services Market - IMG2
  • The market for bioanalytical testing services market is anticipated to grow at a CAGR of 7.3% till 2035, owing to technological advancements in analytical methods like mass spectrometry and AI integration.
Bioanalytical Testing Services Market - IMG3
  • In the current year, North America is expected to capture a significant market share of the overall bioanalytical testing services market, and this trend is unlikely to change in the future as well.
  • Driven by numerous tangible factors, such as the presence of several service providers and easy access to advanced technologies, the bioanalytical testing services market in the US is likely to grow at steady rate.

Bioanalytical Testing Services Market

The market sizing and opportunity analysis has been segmented across the following parameters:

By Type of Testing

  • Pharmacokinetics
  • Pharmacodynamics
  • Bioequivalence
  • Other Tests

By Type of Modality

  • Monoclonal Antibodies
  • Cell Therapies
  • Gene Therapies
  • Biosimilars
  • Fusion Proteins
  • Traditional viral-based Therapies
  • Other Biologics
  • By End-user

By End-user

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations / Contract Development and Manufacturing Organizations
  • Academic and Research Institutes
  • By Geographical Regions

By Geographical Regions

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Middle East and North Africa
  • Saudi Arabia
  • Egypt
  • Rest of Middle East and North Africa
  • Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

Bioanalytical Testing Market: Key Segments

Pharmacokinetics Driving the Bioanalytical Testing Sector

According to the bioanalytical testing services market, the pharmacokinetics sub-segment currently holds a 45% market share due to its crucial role in comprehending a drug's absorption, distribution, metabolism, and excretion. During drug development and regulatory approval, these factors affect safety evaluations, therapeutic efficacy, and dosage optimization. During the forecast period, bioequivalency testing is expected to rise at a higher CAGR, demonstrating significant growth potential. This trend is driven by global initiatives from governments and payers to encourage the adoption of biosimilars and generics, with the aim of reducing drug costs and improving patient access.

Biotechnology and Pharmaceutical Businesses Will Lead the Sector

The bioanalytical testing services market forecast indicates that pharmaceutical and biotechnology firms is likely dominate (~50%) the market in the current year due to the growing usage of advanced molecular testing technologies. This is due to their large capital expenditures, excellent R&D skills, and reliable pipelines of cutting-edge biologics designed to tackle the growing global burden of health issues. During the projected period, CROs and CDMOs are expected to increase at a higher CAGR (8.6%), indicating significant growth potential.

The Market is Dominated by North America

North America will hold the largest market share (50%) for bioanalytical testing in 2035. This is because the need for bioanalytical testing services is being driven by a huge number of pharmaceutical and biotechnology industries.

Growth of the Asia Pacific Bioanalytical Testing Market

During the forecast period, the Asia-Pacific bioanalytical testing services market is expected to grow at a CAGR of 8.6%. This is because regional R&D and clinical trial activity in biotechnology and pharmaceuticals has grown at an accelerated rate.

Primary Research Overview

Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The market report includes detailed transcripts of interviews conducted with the following individuals:

  • Business Development Officer, Mid-sized Organization, Australia

In addition, the Bioanalytical Testing Services Market report includes transcripts of the following other third-party discussions:

  • Founder and Chief Executive, Officer, Large Organization, US
  • Executive Vice President of Global Bioanalytical Services, Small Organization, Singapore
  • Principal Investigator, US
  • Executive Director, Large Organization, US
  • R&D Analytical Development Manager, Large Organization, France
  • Senior Scientist, Large Organization, US
  • Lab Director, Very Large Organization, US
  • Bioanalytical Operational Head, Large Organization, US
  • Development Lead, Large Organization, France
  • Director, Large Organization, Canada

Example Players in Bioanalytical Testing Services Market

  • BioAgilytix
  • Catalent
  • Charles River Laboratories
  • Clean Cells
  • Coriolis Pharma
  • Eurofins
  • Genezen
  • SGS
  • Solvias
  • Texcell
  • Wuxi AppTec

Bioanalytical Testing Market: Research Coverage

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the bioanalytical testing market, focusing on key market segments, including [A] type of testing [B] type of modality, [C] end-user, and [D] geographical regions.
  • Bioanalytical Testing Market Landscape: A detailed assessment of the overall medical device contract manufacturers market landscape, along with information on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of testing offered, [E] type of modality, [F] type of workflow, [G] type of technology and [H] end users.
  • Company Profiles: In-depth profiles of leading players engaged in medical device contract manufacturers market based on [A] year of establishment, [B] location of headquarters, [C] product portfolio, [D] recent developments and [E] an informed future outlook.
  • Company Competitiveness Analysis: A competitiveness analysis of bioanalytical testing service providers based on [A] company strength, [B] service strength and [C] number of end users.
  • Market Impact Analysis: An in-depth analysis of the factors that can impact the growth of the bioanalytical testing services market. It also features identification and market analysis of [A] key drivers, [B] potential restraints, [C] emerging opportunities, and [D] existing challenges.

Key Questions Answered in this Report

  • Which are the leading companies in the bioanalytical testing market?
  • Which region dominates the bioanalytical testing market?
  • What are the key trends observed in the bioanalytical testing market?
  • What factors are likely to influence the evolution of this market?
  • What are the primary challenges faced by bioanalytical testing providers?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
  • The report can aid businesses in identifying future opportunities in any sector. It also helps in understanding if those opportunities are worth pursuing.
  • The report helps in identifying customer demand by understanding the needs, preferences, and behavior of the target audience in order to tailor products or services effectively.
  • The report equips new entrants with requisite information regarding a particular market to help them build successful business strategies.
  • The report allows for more effective communication with the audience and in building strong business relations.

Additional Benefits

  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. BACKGROUND

  • 1.1. Context
  • 1.2. Project Objectives

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
    • 2.2.1. Market Landscape and Market Trends
    • 2.2.2. Market Forecast and Opportunity Analysis
    • 2.2.3. Comparative Analysis
  • 2.3. Database Building
    • 2.3.1. Data Collection
    • 2.3.2. Data Validation
    • 2.3.3. Data Analysis
  • 2.4. Project Methodology
    • 2.4.1. Secondary Research
      • 2.4.1.1. Annual Reports
      • 2.4.1.2. Academic Research Papers
      • 2.4.1.3. Company Websites
      • 2.4.1.4. Investor Presentations
      • 2.4.1.5. Regulatory Filings
      • 2.4.1.6. White Papers
      • 2.4.1.7. Industry Publications
      • 2.4.1.8. Conferences and Seminars
      • 2.4.1.9. Government Portals
      • 2.4.1.10. Media and Press Releases
      • 2.4.1.11. Newsletters
      • 2.4.1.12. Industry Databases
      • 2.4.1.13. Roots Proprietary Databases
      • 2.4.1.14. Paid Databases and Sources
      • 2.4.1.15. Social Media Portals
      • 2.4.1.16. Other Secondary Sources
    • 2.4.2. Primary Research
      • 2.4.2.1. Types of Primary Research
        • 2.4.2.1.1. Qualitative Research
        • 2.4.2.1.2. Quantitative Research
        • 2.4.2.1.3. Hybrid Approach
      • 2.4.2.2. Advantages of Primary Research
      • 2.4.2.3. Techniques for Primary Research
        • 2.4.2.3.1. Interviews
        • 2.4.2.3.2. Surveys
        • 2.4.2.3.3. Focus Groups
        • 2.4.2.3.4. Observational Research
        • 2.4.2.3.5. Social Media Interactions
      • 2.4.2.4. Key Opinion Leaders Considered in Primary Research
        • 2.4.2.4.1. Company Executives (CXOs)
        • 2.4.2.4.2. Board of Directors
        • 2.4.2.4.3. Company Presidents and Vice Presidents
        • 2.4.2.4.4. Research and Development Heads
        • 2.4.2.4.5. Technical Experts
        • 2.4.2.4.6. Subject Matter Experts
        • 2.4.2.4.7. Scientists
        • 2.4.2.4.8. Doctors and Other Healthcare Providers
      • 2.4.2.5. Ethics and Integrity
        • 2.4.2.5.1. Research Ethics
        • 2.4.2.5.2. Data Integrity
    • 2.4.3. Analytical Tools and Databases
  • 2.5. Robust Quality Control

3. MARKET DYNAMICS

  • 3.1. Chapter Overview
  • 3.2. Forecast Methodology
    • 3.2.1. Top-down Approach
    • 3.2.2. Bottom-up Approach
    • 3.2.3. Hybrid Approach
  • 3.3. Market Assessment Framework
    • 3.3.1. Total Addressable Market (TAM)
    • 3.3.2. Serviceable Addressable Market (SAM)
    • 3.3.3. Serviceable Obtainable Market (SOM)
    • 3.3.4. Currently Acquired Market (CAM)
  • 3.4. Forecasting Tools and Techniques
    • 3.4.1. Qualitative Forecasting
    • 3.4.2. Correlation
    • 3.4.3. Regression
    • 3.4.4. Extrapolation
    • 3.4.5. Convergence
    • 3.4.6. Sensitivity Analysis
    • 3.4.7. Scenario Planning
    • 3.4.8. Data Visualization
    • 3.4.9. Time Series Analysis
    • 3.4.10. Forecast Error Analysis
  • 3.5. Key Considerations
    • 3.5.1. Demographics
    • 3.5.2. Government Regulations
    • 3.5.3. Reimbursement Scenarios
    • 3.5.4. Market Access
    • 3.5.5. Supply Chain
    • 3.5.6. Industry Consolidation
    • 3.5.7. Pandemic / Unforeseen Disruptions Impact
  • 3.6. Limitations

4. MACRO-ECONOMIC INDICATORS

  • 4.1. Chapter Overview
  • 4.2. Market Dynamics
    • 4.2.1. Time Period
      • 4.2.1.1. Historical Trends
      • 4.2.1.2. Current and Forecasted Estimates
    • 4.2.2. Currency Coverage
      • 4.2.2.1. Major Currencies Affecting the Market
      • 4.2.2.2. Factors Affecting Currency Fluctuations in the Industry
      • 4.2.2.3. Impact of Currency Fluctuations on the Industry
    • 4.2.3. Foreign Currency Exchange Rate
      • 4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
      • 4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 4.2.4. Recession
      • 4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
      • 4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
    • 4.2.5. Inflation
      • 4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 4.2.5.2. Potential Impact of Inflation on the Market Evolution
    • 4.2.6. Interest Rates
      • 4.2.6.1. Interest Rates and Their Impact on the Market
      • 4.2.6.2. Strategies for Managing Interest Rate Risk
    • 4.2.7. Commodity Flow Analysis
      • 4.2.7.1. Type of Commodity
      • 4.2.7.2. Origins and Destinations
      • 4.2.7.3. Values and Weights
      • 4.2.7.4. Modes of Transportation
    • 4.2.8. Global Trade Dynamics
      • 4.2.8.1. Import Scenario
      • 4.2.8.2. Export Scenario
      • 4.2.8.3. Trade Policies
      • 4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
      • 4.2.8.5. Impact of Trade Barriers on the Market
    • 4.2.9. War Impact Analysis
      • 4.2.9.1. Russian-Ukraine War
      • 4.2.9.2. Israel-Hamas War
    • 4.2.10. COVID Impact / Related Factors
      • 4.2.10.1. Global Economic Impact
      • 4.2.10.2. Industry-specific Impact
      • 4.2.10.3. Government Response and Stimulus Measures
      • 4.2.10.4. Future Outlook and Adaptation Strategies
    • 4.2.11. Other Indicators
      • 4.2.11.1. Fiscal Policy
      • 4.2.11.2. Consumer Spending
      • 4.2.11.3. Gross Domestic Product
      • 4.2.11.4. Employment
      • 4.2.11.5. Taxes
      • 4.2.11.6. Stock Market Performance
      • 4.2.11.7. Cross Border Dynamics
  • 4.3. Conclusion

5. EXECUTIVE SUMMARY

  • 5.1. Executive Summary: Market Landscape
  • 5.2. Executive Summary: Market Forecast

6. INTRODUCTION

  • 6.1. Chapter Overview
  • 6.2. Overview of Bioanalytical Testing Services
  • 6.3. Type of Bioanalytical Testing
  • 6.4. Advantages of Bioanalytical Testing
  • 6.5. Challenges of Bioanalytical Testing
  • 6.6. Recent Development in Bioanalytical Testing Domain
  • 6.7. Future Perspective

7. MARKET LANDSCAPE

  • 7.1. Bioanalytical Testing Service Providers: Market Landscape
    • 7.1.1. Analysis by Type of Testing Offered
    • 7.1.2. Analysis by Type of Modality
    • 7.1.3. Analysis by Type of Workflow
    • 7.1.4. Analysis by Type of Technology
    • 7.1.5. Analysis by End Users
    • 7.1.6. Analysis by Year of Establishment
    • 7.1.7. Analysis by Company Size
    • 7.1.8. Analysis by Location of Headquarters

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Methodology and Key Parameters
  • 8.2. Scoring Criteria
  • 8.3. Peer Groups
    • 8.3.1. Service Providers Offering Services for Peptides
    • 8.3.2. Service Providers Offering Services for Monoclonal Antibodies
    • 8.3.3. Service Providers Offering Services for Gene Therapies
    • 8.3.4. Service Providers Offering Services for Cell Therapies
    • 8.3.5. Service Providers Offering Services for Vaccines
    • 8.3.6. Service Providers Offering Services for Biosimilars
    • 8.3.7. Service Providers Offering Services for Vectors
    • 8.3.8. Service Providers Offering Services for Fusion Proteins
    • 8.3.9. Service Providers Offering Services for mRNA
    • 8.3.10. Service Providers Offering Services for Other Biologics
    • 8.3.11. Service Providers Offering Services for Small Molecules

9. COMPANY PROFILES: BIOANALYTICAL TESTING SERVICE PROVIDERS

  • 9.1. BioAgilytix Labs
    • 9.1.1. Company Details
    • 9.1.2. Service Portfolio
    • 9.1.3. Future Outlook
  • 9.2. Catalent
    • 9.2.1. Company Details
    • 9.2.2. Service Portfolio
    • 9.2.3. Financial Details
    • 9.2.4. Future Outlook
  • 9.3. Charles River Laboratories
    • 9.3.1. Company Details
    • 9.3.2. Service Portfolio
    • 9.3.3. Financial Details
    • 9.3.4. Future Outlook
  • 9.4. Clean Cells
    • 9.4.1. Company Details
    • 9.4.2. Service Portfolio
    • 9.4.3. Financial Details
    • 9.4.4. Future Outlook
  • 9.5. Coriolis Pharma
    • 9.5.1. Company Details
    • 9.5.2. Service Portfolio
    • 9.5.3. Financial Details
    • 9.5.4. Future Outlook
  • 9.6. Eurofins
    • 9.6.1. Company Details
    • 9.6.2. Service Portfolio
    • 9.6.3. Financial Details
    • 9.6.4. Future Outlook
  • 9.7. SGS
    • 9.7.1. Company Details
    • 9.7.2. Service Portfolio
    • 9.7.3. Financial Details
    • 9.7.4. Future Outlook
  • 9.8. Solvias
    • 9.8.1. Company Details
    • 9.8.2. Service Portfolio
    • 9.8.3. Financial Details
    • 9.8.4. Future Outlook
  • 9.9. Texcells
    • 9.9.1. Company Details
    • 9.9.2. Service Portfolio
    • 9.9.3. Financial Details
    • 9.9.4. Future Outlook
  • 9.10. Wuxi Apptech
    • 9.10.1. Company Details
    • 9.10.2. Service Portfolio
    • 9.10.3. Financial Details
    • 9.10.4. Future Outlook

10. MARKET IMPACT ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Market Drivers
  • 10.3. Market Restraints
  • 10.4. Market Opportunities
  • 10.5. Market Challenges

11. GLOBAL BIOANALYTICAL TESTNG MARKET

  • 11.1. Key Assumptions and Methodology
  • 11.2. Global Bioanalytical Testing Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 11.2.1. Roots Analysis Perspective on Market Growth
    • 11.2.2. Scenario Analysis
      • 11.2.2.1. Conservative Scenario
      • 11.2.2.2. Optimistic Scenario
  • 11.3. Key Market Segmentations

12. BIOANALYTICAL TESTING MARKET, BY TYPE OF TESTING OFFERED

  • 12.1. Key Assumptions and Methodology
  • 12.2. Bioanalytical Testing Market: Distribution by Type of Testing Offered
    • 12.2.1. Bioanalytical Testing Market for Pharmacokinetics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 12.2.2. Bioanalytical Testing Market for Pharmacodynamics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 12.2.3. Bioanalytical Testing Market for Bioavailability, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 12.2.4. Bioanalytical Testing Market for Bioequivalence, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 12.2.5. Bioanalytical Testing Market for Other Tests, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 12.3. Data Triangulation and Validation

13. BIOANALYTICAL TESTING MARKET, BY TYPE OF MODALITY

  • 13.1. Key Assumptions and Methodology
  • 13.2. Bioanalytical Testing Market: Distribution by Type of Modality
    • 13.2.1. Bioanalytical Testing Market for Monoclonal Antibodies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 13.2.2. Bioanalytical Testing Market for Cell Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 13.2.3. Bioanalytical Testing Market for Gene Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 13.2.4. Bioanalytical Testing Market for Biosimilars, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 13.2.5. Bioanalytical Testing Market for Fusion Proteins, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 13.2.6. Bioanalytical Testing Market for Traditional Viral Based Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 13.2.7. Bioanalytical Testing Market for Other Biologics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 13.3. Data Triangulation and Validation

14. BIOANALYTICAL TESTING MARKET, BY END USERS

  • 14.1. Key Assumptions and Methodology
  • 14.2. Bioanalytical Testing Market: Distribution by Type of End Users
    • 14.2.1. Bioanalytical Testing Market for Pharmaceuticals and Biotechnology Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 14.2.2. Bioanalytical Testing Market for CROs and CDMOs, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 14.2.3. Bioanalytical Testing Market for Academic and Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

15. BIOANALYTICAL TESTING MARKET, BY GEOGRAPHICAL REGIONS

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Bioanalytical Testing Market: Distribution by Geographical Regions
    • 15.3.1. Bioanalytical Testing Market in North America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.1.1. Bioanalytical Testing Market in the US, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.1.2. Bioanalytical Testing Market in Canada, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 15.3.2. Bioanalytical Testing Market in Europe, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.2.1. Bioanalytical Testing Market in Germany, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.2.2. Bioanalytical Testing Market in the UK, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.2.3. Bioanalytical Testing Market in France, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.2.4. Bioanalytical Testing Market in Italy, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.2.5. Bioanalytical Testing Market in Spain, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.2.6. Bioanalytical Testing Market in Rest of the Europe, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 15.3.3. Bioanalytical Testing Market in Asia-Pacific, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.3.1. Bioanalytical Testing Market in China, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.3.2. Bioanalytical Testing Market in India, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.3.3. Bioanalytical Testing Market in Japan, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.3.4. Bioanalytical Testing Market in South Korea, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.3.5. Bioanalytical Testing Market in Rest of Asia-Pacific, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 15.3.4. Bioanalytical Testing Market in Latin America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.4.1. Bioanalytical Testing Market in Brazil, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.4.2. Bioanalytical Testing Market in Argentina, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.4.3. Bioanalytical Testing Market in Rest of Latin America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 15.3.5. Bioanalytical Testing Market in Middle East and North Africa, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.5.1. Bioanalytical Testing Market in Saudi Arabia, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.5.2. Bioanalytical Testing Market in Egypt, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
      • 15.3.5.3. Bioanalytical Testing Market in Rest of Middle East and North Africa, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 15.3.6. Penetration Growth (P-G) Matrix
    • 15.3.7. Market Movement Analysis
  • 15.4. Data Triangulation and Validation

16. MARKET OPPORTUNITY ANALYSIS: NORTH AMERICA

  • 16.1. Bioanalytical Testing Market in North America: Distribution by Type of Testing
    • 16.1.1. Bioanalytical Testing Market in North America for Pharmacokinetics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.1.2. Bioanalytical Testing Market in North America for Pharmacodynamics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.1.3. Bioanalytical Testing Market in North America for Bioavailability, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.1.4. Bioanalytical Testing Market in North America for Bioequivalence, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.1.5. Bioanalytical Testing Market in North America for Other Tests, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 16.2. Bioanalytical Testing Market in North America: Distribution by Type of Modality
    • 16.2.1. Bioanalytical Testing Market in North America for Monoclonal Antibodies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.2.2. Bioanalytical Testing Market in North America for Cell Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.2.3. Bioanalytical Testing Market in North America for Gene Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.2.4. Bioanalytical Testing Market in North America for Biosimilars, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.2.5. Bioanalytical Testing Market in North America for Fusion Proteins, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.2.6. Bioanalytical Testing Market in North America for Traditional Viral Based Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.2.7. Bioanalytical Testing Market in North America for Other Biologics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 16.3. Bioanalytical Testing Market in North America: Distribution by End Users
    • 16.3.1. Bioanalytical Testing Market in North America for Pharmaceuticals and Biotechnology Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.3.2. Bioanalytical Testing Market in North America for CROs and CDMOs, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 16.3.3. Bioanalytical Testing Market in North America for Academic and Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

17. MARKET OPPORTUNITY ANALYSIS: EUROPE

  • 17.1. Bioanalytical Testing Market in Europe: Distribution by Type of Testing
    • 17.1.1. Bioanalytical Testing Market in Europe for Pharmacokinetics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.1.2. Bioanalytical Testing Market in Europe for Pharmacodynamics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.1.3. Bioanalytical Testing Market in Europe for Bioavailability, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.1.4. Bioanalytical Testing Market in Europe for Bioequivalence, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.1.5. Bioanalytical Testing Market in Europe for Other Tests, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 17.2. Bioanalytical Testing Market in Europe: Distribution by Type of Modality
    • 17.2.1. Bioanalytical Testing Market in Europe for Monoclonal Antibodies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.2.2. Bioanalytical Testing Market in Europe for Cell Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.2.3. Bioanalytical Testing Market in Europe for Gene Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.2.4. Bioanalytical Testing Market in Europe for Biosimilars, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.2.5. Bioanalytical Testing Market in Europe for Fusion Proteins, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.2.6. Bioanalytical Testing Market in Europe for Traditional Viral Based Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.2.7. Bioanalytical Testing Market in Europe for Other Biologics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 17.3. Bioanalytical Testing Market in Europe: Distribution by End Users
    • 17.3.1. Bioanalytical Testing Market in Europe for Pharmaceuticals and Biotechnology Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.3.2. Bioanalytical Testing Market in Europe for CROs and CDMOs, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 17.3.3. Bioanalytical Testing Market in Europe for Academic and Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

18. MARKET OPPORTUNITY ANALYSIS: ASIA PACIFIC

  • 18.1. Bioanalytical Testing Market in Asia-Pacific: Distribution by Type of Testing
    • 18.1.1. Bioanalytical Testing Market in Asia-Pacific for Pharmacokinetics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.1.2. Bioanalytical Testing Market in Asia-Pacific for Pharmacodynamics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.1.3. Bioanalytical Testing Market in Asia-Pacific for Bioavailability, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.1.4. Bioanalytical Testing Market in Asia-Pacific for Bioequivalence, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.1.5. Bioanalytical Testing Market in Asia-Pacific for Other Tests, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 18.2. Bioanalytical Testing Market in Asia-Pacific: Distribution by Type of Modality
    • 18.2.1. Bioanalytical Testing Market in Asia-Pacific for Monoclonal Antibodies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.2.2. Bioanalytical Testing Market in Asia-Pacific for Cell Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.2.3. Bioanalytical Testing Market in Asia-Pacific for Gene Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.2.4. Bioanalytical Testing Market in Asia-Pacific for Biosimilars, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.2.5. Bioanalytical Testing Market in Asia-Pacific for Fusion Proteins, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.2.6. Bioanalytical Testing Market in Asia-Pacific for Traditional Viral Based Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.2.7. Bioanalytical Testing Market in Asia-Pacific for Other Biologics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 18.3. Bioanalytical Testing Market in Asia-Pacific: Distribution by End Users
    • 18.3.1. Bioanalytical Testing Market in Asia-Pacific for Pharmaceuticals and Biotechnology Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.3.2. Bioanalytical Testing Market in Asia-Pacific for CROs and CDMOs, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 18.3.3. Bioanalytical Testing Market in Asia-Pacific for Academic and Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

19. MARKET OPPORTUNITY ANALYSIS: LATIN AMERICA

  • 19.1. Bioanalytical Testing Market in Latin America: Distribution by Type of Testing
    • 19.1.1. Bioanalytical Testing Market in Latin America for Pharmacokinetics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.1.2. Bioanalytical Testing Market in Latin America for Pharmacodynamics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.1.3. Bioanalytical Testing Market in Latin America for Bioavailability, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.1.4. Bioanalytical Testing Market in Latin America for Bioequivalence, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.1.5. Bioanalytical Testing Market in Latin America for Other Tests, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 19.2. Bioanalytical Testing Market in Latin America: Distribution by Type of Modality
    • 19.2.1. Bioanalytical Testing Market in Latin America for Monoclonal Antibodies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.2.2. Bioanalytical Testing Market in Latin America for Cell Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.2.3. Bioanalytical Testing Market in Latin America for Gene Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.2.4. Bioanalytical Testing Market in Latin America for Biosimilars, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.2.5. Bioanalytical Testing Market in Latin America for Fusion Proteins, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.2.6. Bioanalytical Testing Market in Latin America for Traditional Viral Based Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.2.7. Bioanalytical Testing Market in Latin America for Other Biologics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 19.3. Bioanalytical Testing Market in Latin America: Distribution by End Users
    • 19.3.1. Bioanalytical Testing Market in Latin America for Pharmaceuticals and Biotechnology Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.3.2. Bioanalytical Testing Market in Latin America for CROs and CDMOs, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 19.3.3. Bioanalytical Testing Market in Latin America for Academic and Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20. MARKET OPPORTUNITY ANALYSIS: Middle East and North Africa

  • 20.1. Bioanalytical Testing Market in Middle East and North Africa: Distribution by Type of Testing
    • 20.1.1. Bioanalytical Testing Market in Middle East and North Africa for Pharmacokinetics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.1.2. Bioanalytical Testing Market in Middle East and North Africa for Pharmacodynamics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.1.3. Bioanalytical Testing Market in Middle East and North Africa for Bioavailability, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.1.4. Bioanalytical Testing Market in Middle East and North Africa for Bioequivalence, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.1.5. Bioanalytical Testing Market in Middle East and North Africa for Other Tests, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 20.2. Bioanalytical Testing Market in Middle East and North Africa: Distribution by Type of Modality
    • 20.2.1. Bioanalytical Testing Market in Middle East and North Africa for Monoclonal Antibodies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.2.2. Bioanalytical Testing Market in Middle East and North Africa for Cell Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.2.3. Bioanalytical Testing Market in Middle East and North Africa for Gene Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.2.4. Bioanalytical Testing Market in Middle East and North Africa for Biosimilars, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.2.5. Bioanalytical Testing Market in Middle East and North Africa for Fusion Proteins, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.2.6. Bioanalytical Testing Market in Middle East and North Africa for Traditional Viral Based Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.2.7. Bioanalytical Testing Market in Middle East and North Africa for Other Biologics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
  • 20.3. Bioanalytical Testing Market in Middle East and North Africa: Distribution by End Users
    • 20.3.1. Bioanalytical Testing Market in Middle East and North Africa for Pharmaceuticals and Biotechnology Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.3.2. Bioanalytical Testing Market in Middle East and North Africa for CROs and CDMOs, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
    • 20.3.3. Bioanalytical Testing Market in Middle East and North Africa for Academic and Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

21. EXECUTIVE INSIGHTS

22. APPENDIX 1: TABULATED DATA

23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 7.1 List of Bioanalytical Testing Service Providers
  • Table 22.1 Bioanalytical Testing Service Providers: Distribution by Type of Testing Offered
  • Table 22.2 Bioanalytical Testing Service Providers: Distribution by Type of Modality
  • Table 22.3 Bioanalytical Testing Service Providers: Distribution by Type of Workflow
  • Table 22.4 Bioanalytical Testing Service Providers: Distribution by Type of Technology
  • Table 22.5 Bioanalytical Testing Service Providers: Distribution by End Users
  • Table 22.6 Bioanalytical Testing Service Providers: Distribution by Year of Establishment
  • Table 22.7 Bioanalytical Testing Service Providers: Distribution by Company Size
  • Table 22.8 Bioanalytical Testing Service Providers: Distribution by Location of Headquarters
  • Table 22.9 Global Bioanalytical Testing Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.10 Global Bioanalytical Testing Market, Forecasted Estimates (Since 2020): Conservative Scenario (USD Billion)
  • Table 22.11 Global Bioanalytical Testing Market, Forecasted Estimates (Since 2020): Optimistic Scenario (USD Billion)
  • Table 22.12 Bioanalytical Testing Market: Distribution by Type of Testing Offered, 2025, 2030, 2035
  • Table 22.13 Bioanalytical Testing Market for Pharmacokinetics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.14 Bioanalytical Testing Market for Pharmacodynamics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.15 Bioanalytical Testing Market for Bioavailability, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.16 Bioanalytical Testing Market for Other Tests, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.17 Bioanalytical Testing Market: Distribution by Type of Modality
  • Table 22.18 Bioanalytical Testing Market for Monoclonal Antibodies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.19 Bioanalytical Testing Market for Cell Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.20 Bioanalytical Testing Market for Gene Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.21 Bioanalytical Testing Market for Biosimilars, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.22 Bioanalytical Testing Market for Fusion Proteins, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.23 Bioanalytical Testing Market for Traditional Viral Based Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.24 Bioanalytical Testing Market for Other Biologics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.25 Bioanalytical Testing Market: Distribution by End Users
  • Table 22.26 Bioanalytical Testing Market for Pharmaceuticals and Biotechnology Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.27 Bioanalytical Testing Market for CROs and CDMOs, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.28 Bioanalytical Testing Market for Academic and Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.29 Bioanalytical Testing Market: Distribution by Key Geographical Regions
  • Table 22.30 Bioanalytical Testing Market in North America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.31 Bioanalytical Testing Market in the US, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.32 Bioanalytical Testing Market in Canada, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.33 Bioanalytical Testing Market in Europe, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.34 Bioanalytical Testing Market in Germany, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.35 Bioanalytical Testing Market in UK, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.36 Bioanalytical Testing Market in France, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.37 Bioanalytical Testing Market in Italy, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.38 Bioanalytical Testing Market in the Spain, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.39 Bioanalytical Testing Market in Rest of Europe, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.40 Bioanalytical Testing Market in Asia-Pacific, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.41 Bioanalytical Testing Market in China, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.42 Bioanalytical Testing Market in Japan, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.43 Bioanalytical Testing Market in India, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.44 Bioanalytical Testing Market in South Korea, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.45 Bioanalytical Testing Market in Rest of the Asia-Pacific, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.46 Bioanalytical Testing Market in Middle East and North Africa, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.47 Bioanalytical Testing Market in Saudi Arabia, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.48 Bioanalytical Testing Market in Egypt, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.49 Bioanalytical Testing Market in Rest of Middle East and North Africa, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.50 Bioanalytical Testing Market in Latin America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.51 Bioanalytical Testing Market in Brazil, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.52 Bioanalytical Testing Market in Argentina, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Table 22.53 Bioanalytical Testing Market in Rest of Latin America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)

List of Figures

  • Figure 2.1 Research Methodology: Project Methodology
  • Figure 2.2 Research Methodology: Data Sources for Secondary Research
  • Figure 2.3 Research Methodology: Robust Quality Control
  • Figure 3.1 Market Dynamics: Forecast Methodology
  • Figure 3.2 Market Dynamics: Key Market Segmentation
  • Figure 4.1 Lessons Learnt from Past Recessions
  • Figure 5.1 Executive Summary: Bioanalytical Testing Service Providers Market Landscape
  • Figure 5.2 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 7.1 Bioanalytical Testing Service Providers: Distribution by Type of Testing Offered
  • Figure 7.2 Bioanalytical Testing Service Providers: Distribution by Type of Modality
  • Figure 7.3 Bioanalytical Testing Service Providers: Distribution by Type of Workflow
  • Figure 7.4 Bioanalytical Testing Service Providers: Distribution by Type of Technology
  • Figure 7.5 Bioanalytical Testing Service Providers: Distribution by End Users
  • Figure 7.6 Bioanalytical Testing Service Providers: Distribution by Year of Establishment
  • Figure 7.7 Bioanalytical Testing Service Providers: Distribution by Company Size
  • Figure 7.8 Bioanalytical Testing Service Providers: Distribution by Headquarters
  • Figure 8.1 Company Competitiveness Analysis: Service Providers offering Services for Peptides
  • Figure 8.2 Company Competitiveness Analysis: Service Providers offering Services for Monoclonal Antibodies
  • Figure 8.3 Company Competitiveness Analysis: Service Providers offering Services for Gene Therapies
  • Figure 8.4 Company Competitiveness Analysis: Service Providers offering Services for Cell Therapies
  • Figure 8.5 Company Competitiveness Analysis: Service Providers offering Services for Vaccines
  • Figure 8.6 Company Competitiveness Analysis: Service Providers offering Services for Biosimilars
  • Figure 8.7 Company Competitiveness Analysis: Service Providers offering Services for Vectors
  • Figure 8.8 Company Competitiveness Analysis: Service Providers offering Services for Fusion Proteins
  • Figure 8.9 Company Competitiveness Analysis: Service Providers offering Services for mRNA
  • Figure 8.10 Company Competitiveness Analysis: Service Providers offering Services for Other Biologics
  • Figure 8.11 Company Competitiveness Analysis: Service Providers offering Services for Small Molecules
  • Figure 9.1 Catalent: Business Segment-wise Revenues and Consolidated Financial Details (DKK Billion)
  • Figure 9.2 Charles River: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
  • Figure 9.3 Eurofins: Business Segment-wise Revenues and Consolidated Financial Details (EUR Million)
  • Figure 9.4 SGS: Business Segment-wise Revenues and Consolidated Financial Details (CHF Billion)
  • Figure 9.5 Wuxi AppTech: Business Segment-wise Revenues and Consolidated Financial Details (RMB Billion)
  • Figure 11.1 Global Bioanalytical Testing Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 11.2 Global Bioanalytical Testing Market, Forecasted Estimates (Since 2020): Conservative Scenario (USD Billion)
  • Figure 11.3 Global Bioanalytical Testing Market, Forecasted Estimates (Since 2020): Optimistic Scenario (USD Billion)
  • Figure 12.1 Bioanalytical Testing Market: Distribution by Type of Testing Offered, 2025, 2030, 2035
  • Figure 12.2 Bioanalytical Testing Market for Pharmacokinetics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 12.3 Bioanalytical Testing Market for Pharmacodynamics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 12.4 Bioanalytical Testing Market for Bioavailability, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 12.5 Bioanalytical Testing Market for Other Tests, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 13.1 Bioanalytical Testing Market: Distribution by Type of Modality
  • Figure 13.2 Bioanalytical Testing Market for Monoclonal Antibodies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 13.3 Bioanalytical Testing Market for Cell Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 13.4 Bioanalytical Testing Market for Gene Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 13.2 Bioanalytical Testing Market for Biosimilars, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 13.3 Bioanalytical Testing Market for Fusion Proteins, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 13.4 Bioanalytical Testing Market for Traditional Viral Based Therapies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 13.4 Bioanalytical Testing Market for Other Biologics, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 14.1 Bioanalytical Testing Market: Distribution by End Users
  • Figure 14.2 Bioanalytical Testing Market for Pharmaceuticals and Biotechnology Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 14.3 Bioanalytical Testing Market for CROs and CDMOs, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 14.4 Bioanalytical Testing Market for Academic and Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.1 Bioanalytical Testing Market: Distribution by Key Geographical Regions
  • Figure 15.2 Bioanalytical Testing Market in North America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.3 Bioanalytical Testing Market in the US, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.4 Bioanalytical Testing Market in Canada, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.5 Bioanalytical Testing Market in Europe, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.6 Bioanalytical Testing Market in Germany, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.7 Bioanalytical Testing Market in UK, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.8 Bioanalytical Testing Market in France, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.9 Bioanalytical Testing Market in Italy, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.10 Bioanalytical Testing Market in the Spain, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.11 Bioanalytical Testing Market in Rest of Europe, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.12 Bioanalytical Testing Market in Asia-Pacific, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.13 Bioanalytical Testing Market in China, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.14 Bioanalytical Testing Market in Japan, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.15 Bioanalytical Testing Market in India, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.16 Bioanalytical Testing Market in South Korea, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.17 Bioanalytical Testing Market in Rest of the Asia-Pacific, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.18 Bioanalytical Testing Market in Middle East and North Africa, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.19 Bioanalytical Testing Market in Saudi Arabia, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.20 Bioanalytical Testing Market in Egypt, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.21 Bioanalytical Testing Market in Rest of Middle East and North Africa, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.22 Bioanalytical Testing Market in Latin America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.23 Bioanalytical Testing Market in Brazil, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.24 Bioanalytical Testing Market in Argentina, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.25 Bioanalytical Testing Market in Rest of Latin America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 15.26 Penetration Growth (P-G) Matrix: Geographical Regions
  • Figure 15.27 Market Movement Analysis: Geographical Regions